HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melittin - A bee venom component - Enhances muscle regeneration factors expression in a mouse model of skeletal muscle contusion.

Abstract
Melittin is a major peptide component of sweet bee venom that possesses anti-allergic, anti-inflammatory, anti-arthritis, anti-cancer, and neuroprotective properties. However, the therapeutic effects of melittin on muscle injury have not been elucidated. We investigated the therapeutic effects of melittin on muscle injury in a mouse model of muscle contusion. The biceps femoris muscle of the mice was injured using drop mass method, and the animals were treated with melittin (4, 20, or 100 μg/kg) for 7 days. Melittin significantly increased: locomotor activity in open field test, and treadmill running activity in a dose-dependent manner to level comparable to the positive control, diclofenac (30 mg/kg). Melittin treatment attenuated the pro-inflammatory cytokine MCP-1, TNF-α and IL-6. The expression of muscle regeneration biomarkers, including MyoD (muscle differentiation marker), myogenin, smooth muscle actin, and myosin heavy chain was markedly increased in the injured muscle tissue of melittin-treated mice, as determined by western blotting and quantitative real-time polymerase chain reaction. These results demonstrate that melittin inhibits inflammatory response and improves muscle damage by regenerating muscles in a mouse model of muscle contusion. Taken together, the results of present study suggest that melittin is a promising candidate for the muscle injury treatment.
AuthorsJae Eun Lee, Vikash Kumar Shah, Eun-Jung Lee, Min-Seok Oh, Jeong June Choi
JournalJournal of pharmacological sciences (J Pharmacol Sci) Vol. 140 Issue 1 Pg. 26-32 (May 2019) ISSN: 1347-8648 [Electronic] Japan
PMID31113730 (Publication Type: Journal Article)
CopyrightCopyright © 2019 The Authors. Production and hosting by Elsevier B.V. All rights reserved.
Chemical References
  • Actins
  • Anti-Inflammatory Agents
  • Bee Venoms
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Inflammation Mediators
  • Interleukin-6
  • MyoD Protein
  • MyoD1 myogenic differentiation protein
  • Myogenin
  • Tumor Necrosis Factor-alpha
  • Melitten
  • Myosin Heavy Chains
Topics
  • Actins (genetics, metabolism)
  • Animals
  • Anti-Inflammatory Agents
  • Bee Venoms (pharmacology, therapeutic use)
  • Chemokine CCL2 (metabolism)
  • Contusions (drug therapy, genetics, metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Gene Expression
  • Inflammation Mediators (metabolism)
  • Interleukin-6 (metabolism)
  • Male
  • Melitten (pharmacology, therapeutic use)
  • Mice, Inbred C57BL
  • Muscle, Skeletal (metabolism)
  • MyoD Protein (genetics, metabolism)
  • Myogenin (genetics, metabolism)
  • Myosin Heavy Chains (genetics, metabolism)
  • Regeneration (genetics)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: